Novartis
Also known as: AAA USA NOVARTIS | Advanced Accelerator Applications, a Novartis company | Alcon, a Novartis Company | Basel Novartis Pharma AG | Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies | Norvartis Pharma, Nuremberg, Germany | Novartiis Pharmaceuticals | Novartis | NOVARTIS | Novartis AG | Novartis Argentina | Novartis Australia | Novartis Austria | Novartis Basel | Novartis Basel +41 61 324 1111 | Novartis Basel+ 41 61 324 1111 | Novartis Basel, Switzerland | Novartis Belgium | Novartis Brazil | Novartis Consumer Health | Novartis Czech Republic | Novartis Denmark | Novartis de Venezuela | Novartis Farma S.p.A. | Novartis Finland | Novartis Gene Therapies, Inc. | Novartis Germany | Novartis Great Britian | Novartis Hungary | Novartis Iceland | Novartis - Including Sites in Germany | Novartis India Ltd. | Novartis Institute for BioMedical Research | Novartis Institute for Tropical Medicine | Novartis Institutes for BioMedical Research | Novartis Institutes for BioMedical Research, Inc. | Novartis Institutes of Biomedical Research | Novartis Investigative | Novartis investigative site | Novartis Investigative Site | Novartis investigator site | Novartis Investigator Site | Novartis Ireland Ltd | Novartis Italy | Novartis Korea Ltd. | Novartis Medical Nutrition | Novartis Norway | NOVARTIS PHARM | Novartis Pharma AG, Basel | Novartis Pharma AG Basel, Switzerland | Novartis Pharma AG, Basel, Switzerland | Novartis Pharma AG, Switzerland | Novartis Pharma B.V. | Novartis Pharmaceutcals | Novartis Pharmaceutical | Novartis Pharmaceuticals | Novartis Pharmaceuticals, Basel +41 61 324 1111. | Novartis Pharmaceuticals Canada | Novartis Pharmaceuticals Corporation | Novartis Pharmaceuticals Corporation (Financial supporter) | Novartis Pharmaceuticals Japan | Novartis Pharmaceuticals, Japan | Novartis Pharmaceuticals UK Limited | Novartis Pharmaceuticasl | Novartis Pharmaceuticlas | Novartis Pharmacuticals | Novartis Pharma K.K. | Novartis Pharmceuticals | Novartis Pharmeceuticals | NOVARTIS PHARMS | NOVARTIS PHARMS CORP | Novartis Poland | Novartis Portugal | Novartis Romania | Novartis Russia | Novartis / Schering AG Germany | Novartis / Schering AG, Germany | Novartis Slovakia | Novartis South Africa | Novartis Spain | Novartis Sverige AB | Novartis Sweden | Novartis United Kingdom | Novartis Vaccines | Novartis Vaccines and Diagnostics (formerly Chiron Vaccines) | Novartis Vaccines and Diagnostics GmbH & Co KG., Germany | Novartis Vaccines and Diagnostics, Inc | Novartis Vaccines and Diagnostics S.r.l. | Novartis Vaccines & Diagnostics | Novartitis Pharmaceuticals | Novarts Pharmaceuticals | Novatis Pharmaceuticals | The Novartis Foundation
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1996First marketed drug
Jan 1, 1996First NDA
May 28, 1996Last known activity
Jun 29, 2026
Timeline
1990s
- Jan 1, 1996
Novartis— Founded
- Jan 1, 1996
Ciba-Geigy— Acquired
- Jan 1, 1996
Sandoz— Acquired - Feb 1, 1997
Systemix— Acquired
2000s
- Apr 21, 2000
rivastigmine— NDA Organization
- Jan 1, 2002
Lek Pharmaceuticals— Acquired
- Jan 1, 2002
Sabex Holdings— Acquired
- Jan 1, 2005
Eon Labs— Acquired
- Jan 1, 2005
Hexal AG— Acquired
- Jan 1, 2006
Chiron— Acquired
- Apr 6, 2007
cefdinir— Marketing Organization
- Jan 1, 2008
Protez Pharmaceuticals— Acquired
- Jul 10, 2008
Speedel Pharma Ltd.— Acquired
- Jan 1, 2009
Corthera— Acquired
2010s
- Jan 1, 2012
Fougera— Acquired
- Apr 19, 2013
brimonidine— NDA Secondary Org
- Oct 22, 2013
Sideris Pharmaceuticals— Acquired
- Jan 1, 2014
CoStim Pharmaceuticals— Acquired
- Jan 1, 2015
Admune Therapeutics— Acquired
- Jan 1, 2015
Spinifex Pharmaceuticals— Acquired
- Oct 18, 2016
Endocyte— Acquired
- Nov 21, 2016
Selexys Pharmaceuticals Corporation— Acquired
- Dec 16, 2016
Ziarco Pharma Ltd— Acquired
- Dec 20, 2016
Encore Vision, Inc.— Acquired
- Jan 22, 2018
Advanced Accelerator Applications— Acquired
- Apr 9, 2018
AveXis, Inc.— Acquired
- Apr 1, 2019
IFM Tre— Acquired
- Nov 25, 2019
The Medicines Company— Acquired
2020s
- Dec 17, 2020
Cadent Therapeutics— Acquired - Apr 7, 2021
Artios— Acquired
- Dec 22, 2021
Gyroscope Therapeutics— Acquired
- Aug 23, 2022
Aerie Pharmaceuticals— Acquired
- Jun 12, 2023
Chinook Therapeutics— Acquired
- Jul 17, 2023
DTX— Acquired
- Feb 6, 2024
MorphoSys— Acquired
- Feb 11, 2025
Anthos Therapeutics, Inc.— Acquired
- Apr 30, 2025
Regulus Therapeutics Inc.— Acquired
- Sep 9, 2025
Tourmaline Bio— Acquired
- Dec 1, 2025
Avidity Biosciences, Inc.— Acquired
Drugs by trial phase (979 distinct, 4756 trials)
Phase 4 (171 own, 57 via acquisition)
Phase 3 (151 own, 82 via acquisition)
Phase 2 (258 own, 71 via acquisition)
Phase 1 (122 own, 46 via acquisition)
Other trials (15 own, 6 via acquisition)
Indications
Approved for
- Acromegaly
- Angina Pectoris
- Arthritis, Gouty
- Arthritis, Juvenile
- Arthritis, Rheumatoid
- Asthma
- Attention Deficit Disorder with Hyperactivity
- Autism Spectrum Disorder
- Basal Cell Carcinoma
- beta-Thalassemia
- Blepharitis
- Breast Neoplasms
- Bronchitis, Chronic
- Candidiasis
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Chronic Kidney Disease-Mineral and Bone Disorder
- Conjunctivitis
- Conjunctivitis, Allergic
- Constipation
- Coronary Artery Disease
- Cryopyrin-Associated Periodic Syndromes
- Cushing Syndrome
- Dementia
- Dermatitis, Atopic
- Diabetes Mellitus, Type 2
- Dysthymic Disorder
- Emphysema
- Epilepsy
- Familial Mediterranean Fever
- Fascioliasis
- Graft Rejection
- Heart Failure
- Hemorrhage
- Herpes Genitalis
- Herpes Labialis
- Herpes Zoster
- Hypercalcemia
- Hypereosinophilic Syndrome
- Hypertension
- Inflammation
- Iron Overload
- Keratitis
- Keratoconjunctivitis Sicca
- Labor, Obstetric
- Leprosy, Lepromatous
- Leukemia, Mast-Cell
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid, Acute
- Major Depressive Disorder
- Malaria
- Malaria, Vivax
- Mastocytosis, Systemic
- Mevalonate Kinase Deficiency
- Multiple Myeloma
- Multiple Sclerosis
- Mydriasis
- Myelodysplastic-Myeloproliferative Diseases
- Myelodysplastic Syndromes
- Myocardial Infarction
- Narcolepsy
- Nausea
- Neoplasms
- Neuroendocrine Tumors
- Ocular Hypertension
- Onychomycosis
- Osteitis Deformans
- Osteoporosis
- Osteoporosis, Postmenopausal
- Ovarian Neoplasms
- Paragonimiasis
- Parasitic Diseases
- Parkinson Disease
- Pheochromocytoma
- Pituitary ACTH Hypersecretion
- Porphyria Cutanea Tarda
- Postoperative Nausea and Vomiting
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prostatic Neoplasms
- Pruritus
- Psoriasis
- Psychotic Disorders
- Pulmonary Disease, Chronic Obstructive
- Rhinitis, Allergic
- Rhinitis, Allergic, Seasonal
- Schizophrenia
- Seizures
- Small Cell Lung Carcinoma
- Spondylarthropathies
- Stomatognathic Diseases
- Urinary Bladder, Overactive
- Urticaria
- Uterine Hemorrhage
- Vascular Headaches
- Venous Thrombosis
- Ventricular Dysfunction, Left
- Vomiting
Studied for
- Abdominal Neoplasms
- Abdominal Pain
- Acne Vulgaris
- Acquired Immunodeficiency Syndrome
- Acromegaly
- ACTH-Secreting Pituitary Adenoma
- ACTH Syndrome, Ectopic
- Acute Coronary Syndrome
- Acute Disease
- Acute Kidney Injury
- Adenocarcinoma
- Adenocarcinoma of Lung
- Adenocarcinoma, Scirrhous
- Adenoma
- Adenoma, Islet Cell
- Adrenocortical Adenoma
- Adrenocortical Carcinoma
- Aggression
- Albuminuria
- Alcoholism
- Alopecia
- Alopecia Areata
- alpha 1-Antitrypsin Deficiency
- Alzheimer Disease
- Amyloidosis
- Amyotrophic Lateral Sclerosis
- Anemia
- Anemia, Aplastic
- Anemia, Diamond-Blackfan
- Anemia, Hemolytic
- Anemia, Iron-Deficiency
- Anemia, Sickle Cell
- Aneurysm
- Angioedema
- Angiolipoma
- Angiomyolipoma
- Ankle Injuries
- Anxiety Disorders
- Aortic Aneurysm
- Aortic Aneurysm, Abdominal
- Aortic Valve Stenosis
- Arrhythmias, Cardiac
- Arteritis
- Arthralgia
- Arthritis
- Arthritis, Gouty
- Arthritis, Juvenile
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Ascites
- Aspergillosis
- Aspergillosis, Allergic Bronchopulmonary
- Asthma
- Astrocytoma
- Atherosclerosis
- Atrial Fibrillation
- Atrophy
- Attention Deficit Disorder with Hyperactivity
- Autoimmune Diseases
- Back Pain
- Bacteremia
- Bacterial Infections
- Basal Cell Carcinoma
- Basal Cell Nevus Syndrome
- Behcet Syndrome
- beta-Thalassemia
- Bipolar Disorder
- Blast Crisis
- Blood Coagulation Disorders
- Blood Platelet Disorders
- Body Weight
- Bone Diseases
- Bone Diseases, Metabolic
- Bone Marrow Diseases
- Bone Neoplasms
- Bone Resorption
- Brain Concussion
- Brain Injuries
- Brain Injuries, Traumatic
- Brain Neoplasms
- Brain Stem Infarctions
- Breast Diseases
- Breast Neoplasms
- Bronchial Diseases
- Bronchiectasis
- Bronchiolitis
- Bronchiolitis Obliterans
- Bronchitis
- Brucellosis
- Bulbo-Spinal Atrophy, X-Linked
- Burkitt Lymphoma
- Burns
- Cachexia
- Capsule Opacification
- Carcinoid Tumor
- Carcinoma
- Carcinoma, Adenoid Cystic
- Carcinoma, Endometrioid
- Carcinoma, Hepatocellular
- Carcinoma in Situ
Marketed drugs (380)
Subsidiaries (35 direct, 64 total across the full acquisition tree)
- Admune Therapeutics
- Advanced Accelerator Applications
- Aerie Pharmaceuticals
- Anthos Therapeutics, Inc.
- Artios
- AveXis, Inc.
- Avidity Biosciences, Inc.
- Cadent Therapeutics
- Chinook Therapeutics
- Chiron
- Ciba-Geigy
- Corthera
- CoStim Pharmaceuticals
- DTX
- Encore Vision, Inc.
- Endocyte
- Eon Labs
- Fougera
- Gyroscope Therapeutics
- Hexal AG
- IFM Tre
- Lek Pharmaceuticals
- MorphoSys
- Protez Pharmaceuticals
- Regulus Therapeutics Inc.
- Sabex Holdings
- Sandoz
- Selexys Pharmaceuticals Corporation
- Sideris Pharmaceuticals
- Speedel Pharma Ltd.
- Spinifex Pharmaceuticals
- Systemix
- The Medicines Company
- Tourmaline Bio
- Ziarco Pharma Ltd
- Annovation BioPharma L2
- Atreus Pharmaceuticals Corporation L2
- AVX Pharma L2
- Basler IG L2
- Biochemie L2
- Cetus L2
- Ciba L2
- Constellation Pharmaceuticals L2
- EBEWE Pharma L2
- Falcon Pharmaceuticals L2
- Funk Brothers Seed Company L2
- Geigy L2
- Genetic Therapy, Inc. L2
- Gerber L2
- Incline Therapeutics L2
- Lanthio Pharma L2
- Matrix Pharmaceutical L2
- Northrup King L2
- Oriel Therapeutics L2
- PathoGenesis L2
- ProFibrix L2
- Rempex Pharmaceuticals L2
- Rogers Seed Co L2
- Savage Labs L2
- Sloning BioTechnology L2
- Targanta L2
- Tenaxis Medical L2
- Wander AG L2
- Parenta Pharmaceuticals L3
Recent trials (50)
- NCT03386071CollaboratorN/A—
- NCT04085653Lead sponsorN/A—
- NCT04334070Lead sponsorN/A—
- NCT04337359Lead sponsorN/A—
- NCT04337359Study directorN/A—
- NCT04337359OfficialN/A—
- NCT04476706Lead sponsorN/A—
- NCT04489433Lead sponsorN/A—
- NCT04544202Lead sponsorN/A—
- NCT04745637Lead sponsorN/A—
- NCT04498871Lead sponsorN/A—
- NCT04837703Lead sponsorN/A—
- NCT04741789Lead sponsorN/A—
- NCT05219266Lead sponsorN/A—
- NCT05269771Lead sponsorN/A—
Details
- Founded
- Basel, CH Jan 1, 1996
- First NDA
- May 28, 1996
- Last known activity
- Jun 29, 2026
Designations held
- Orphan drug
- Fast track
- Priority review
- Breakthrough therapy
- Accelerated approval